Literature DB >> 23788503

Parsing good versus bad signaling pathways in the heart: role of calcineurin-nuclear factor of activated T-cells.

Jeffery D Molkentin1.   

Abstract

Nine years ago, we published an article that suggested a specialized role for calcineurin–nuclear factor of activated T-cells (NFAT) signaling in regulating pathological cardiac hypertrophy preferentially over physiological growth and, in fact, the later response was associated with reduced calcineurin-NFAT activity. Since this time we and others have continued to uncover how this signaling effector pathway functions in the heart in regulating specific aspects of the growth response during disease and with exercise.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23788503      PMCID: PMC3836615          DOI: 10.1161/CIRCRESAHA.113.301667

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

Review 1.  Transcriptional regulation by calcium, calcineurin, and NFAT.

Authors:  Patrick G Hogan; Lin Chen; Julie Nardone; Anjana Rao
Journal:  Genes Dev       Date:  2003-09-15       Impact factor: 11.361

2.  Impaired cardiac hypertrophic response in Calcineurin Abeta -deficient mice.

Authors:  Orlando F Bueno; Benjamin J Wilkins; Kevin M Tymitz; Betty J Glascock; Thomas F Kimball; John N Lorenz; Jeffery D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth.

Authors:  Benjamin J Wilkins; Leon J De Windt; Orlando F Bueno; Julian C Braz; Betty J Glascock; Thomas F Kimball; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.

Authors:  Qiangrong Liang; Orlando F Bueno; Benjamin J Wilkins; Chia-Yi Kuan; Ying Xia; Jeffery D Molkentin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

5.  Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy.

Authors:  Stephanie A Parsons; Douglas P Millay; Benjamin J Wilkins; Orlando F Bueno; Gretchen L Tsika; Joel R Neilson; Christine M Liberatore; Katherine E Yutzey; Gerald R Crabtree; Richard W Tsika; Jeffery D Molkentin
Journal:  J Biol Chem       Date:  2004-04-13       Impact factor: 5.157

Review 6.  Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Jeffery D Molkentin
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

7.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

8.  NFATc3 is required for intermittent hypoxia-induced hypertension.

Authors:  Sergio de Frutos; Laura Duling; Dominique Alò; Tammy Berry; Olan Jackson-Weaver; Mary Walker; Nancy Kanagy; Laura González Bosc
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

9.  Cholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivo.

Authors:  Grzegorz T Gurda; LiLi Guo; Sae-Hong Lee; Jeffery D Molkentin; John A Williams
Journal:  Mol Biol Cell       Date:  2007-10-31       Impact factor: 4.138

10.  Calcineurin Abeta gene targeting predisposes the myocardium to acute ischemia-induced apoptosis and dysfunction.

Authors:  Orlando F Bueno; Daniel J Lips; Robert A Kaiser; Benjamin J Wilkins; Yan-Shan Dai; Betty J Glascock; Raisa Klevitsky; Timothy E Hewett; Thomas R Kimball; Bruce J Aronow; Pieter A Doevendans; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-11-13       Impact factor: 17.367

View more
  17 in total

1.  Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.

Authors:  Xiaofeng Li; Jinliang Li; Eliana C Martinez; Alexander Froese; Catherine L Passariello; Kathryn Henshaw; Francesca Rusconi; Yang Li; Qian Yu; Hrishikesh Thakur; Viacheslav O Nikolaev; Michael S Kapiloff
Journal:  Circulation       Date:  2020-07-02       Impact factor: 29.690

Review 2.  How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.

Authors:  Zaffar K Haque; Da-Zhi Wang
Journal:  Cell Mol Life Sci       Date:  2016-10-06       Impact factor: 9.261

3.  Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.

Authors:  Ida G Lunde; J Magnus Aronsen; A Olav Melleby; Mari E Strand; Jonas Skogestad; Bård A Bendiksen; M Shakil Ahmed; Ivar Sjaastad; Håvard Attramadal; Cathrine R Carlson; Geir Christensen
Journal:  Mol Biol Rep       Date:  2022-10-07       Impact factor: 2.742

Review 4.  The Role of Exercise in Cardiac Aging: From Physiology to Molecular Mechanisms.

Authors:  Jason Roh; James Rhee; Vinita Chaudhari; Anthony Rosenzweig
Journal:  Circ Res       Date:  2016-01-22       Impact factor: 17.367

Review 5.  The secret messages between mitochondria and nucleus in muscle cell biology.

Authors:  Roman Barbara Soledad; Steenbergen Charles; Das Samarjit
Journal:  Arch Biochem Biophys       Date:  2019-03-30       Impact factor: 4.013

6.  A new stone for a new path, from "physiology to the bedside".

Authors:  Yin Hua Zhang; Jin Han
Journal:  Pflugers Arch       Date:  2019-07-03       Impact factor: 3.657

7.  Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Atsushi Tanaka; Shinsuke Yuasa; Giulia Mearini; Toru Egashira; Tomohisa Seki; Masaki Kodaira; Dai Kusumoto; Yusuke Kuroda; Shinichiro Okata; Tomoyuki Suzuki; Taku Inohara; Takuro Arimura; Shinji Makino; Kensuke Kimura; Akinori Kimura; Tetsushi Furukawa; Lucie Carrier; Koichi Node; Keiichi Fukuda
Journal:  J Am Heart Assoc       Date:  2014-11-11       Impact factor: 5.501

Review 8.  Ongoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?

Authors:  Sebastian Spaich; Hugo A Katus; Johannes Backs
Journal:  Front Physiol       Date:  2015-07-22       Impact factor: 4.566

9.  TRPC3 contributes to regulation of cardiac contractility and arrhythmogenesis by dynamic interaction with NCX1.

Authors:  Bernhard Doleschal; Uwe Primessnig; Gerald Wölkart; Stefan Wolf; Michaela Schernthaner; Michaela Lichtenegger; Toma N Glasnov; C Oliver Kappe; Bernd Mayer; Gudrun Antoons; Frank Heinzel; Michael Poteser; Klaus Groschner
Journal:  Cardiovasc Res       Date:  2015-01-28       Impact factor: 13.081

Review 10.  Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.

Authors:  Mostafa Samak; Javid Fatullayev; Anton Sabashnikov; Mohamed Zeriouh; Bastian Schmack; Mina Farag; Aron-Frederik Popov; Pascal M Dohmen; Yeong-Hoon Choi; Thorsten Wahlers; Alexander Weymann
Journal:  Med Sci Monit Basic Res       Date:  2016-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.